Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570544 · ClinicalTrials.gov registry record
Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
A clinical trial, sponsored by Gelb, Arthur F., M.D..
- Completed
- Registry status
- 29
- Enrollment target
NCT00570544 is a clinical trial that has completed, run by Gelb, Arthur F., M.D.. The registered enrollment target is 29 participants.
The verdict
NCT00570544 has completed, sponsored by Gelb, Arthur F., M.D..
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
To evaluate if tiotropium (Spiriva)induced bronchodilation of inspiratory capacity in patients with moderate to severe copd subjected to metronome paced hyperventilation induced dynamic hyperinflation is dependent upon the extent of underlying emphysema as determined by high resolution-thin section CT lung.
Interventions
- DRUG tiotropium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00570544
The ClinicalTrials.gov registry entry for NCT00570544 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gelb, Arthur F., M.D., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tiotropium is the first listed.
NCT00570544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00570544 about?
NCT00570544 is a clinical study titled "Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema". To evaluate if tiotropium (Spiriva)induced bronchodilation of inspiratory capacity in patients with moderate to severe copd subjected to metronome paced hyperventilation induced dynamic hyperinflation is dependent upon the extent of underlying emphysema as determined by high resolution-thin section ...
What is the current status of trial NCT00570544?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2004-08. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00570544?
The interventions under investigation include: tiotropium (DRUG).
Who is sponsoring clinical trial NCT00570544?
This trial is sponsored by Gelb, Arthur F., M.D., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.